IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel
FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed
Letter to the Editor: A Victory for Research, But Real Work Is Ahead
Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research
Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects
Funding Opportunities: RFA Available: Teams For Molecular Target Assessment
In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies